{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:05:34Z","timestamp":1758056734009,"version":"3.44.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43009794"],"award-info":[{"award-number":["43009794"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11517-025-03365-3","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T22:31:40Z","timestamp":1746657100000},"page":"2955-2968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning assisted identification of SCUBE2 and SLC16 A5 combination in RNA-sequencing data as a novel specific potential diagnostic biomarker in prostate cancer"],"prefix":"10.1007","volume":"63","author":[{"given":"Saeideh","family":"Khorshid Sokhangouy","sequence":"first","affiliation":[]},{"given":"Mohsen","family":"Zeinali","sequence":"additional","affiliation":[]},{"given":"Sina","family":"Fathi","sequence":"additional","affiliation":[]},{"given":"Elham","family":"Nazari","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"6","key":"3365_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","volume":"46","author":"M Nguyen-Nielsen","year":"2016","unstructured":"Nguyen-Nielsen M, Borre M (2016) Diagnostic and therapeutic strategies for prostate cancer. Semin Nucl Med 46(6):484\u2013490","journal-title":"Semin Nucl Med"},{"issue":"2","key":"3365_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajur.2018.11.007","volume":"6","author":"JL Descotes","year":"2019","unstructured":"Descotes JL (2019) Diagnosis of prostate cancer. Asian J Urol 6(2):129\u2013136","journal-title":"Asian J Urol"},{"key":"3365_CR3","doi-asserted-by":"publisher","first-page":"991330","DOI":"10.3389\/fcell.2022.991330","volume":"10","author":"S Belkahla","year":"2022","unstructured":"Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben AN (2022) Advances and development of prostate cancer, treatment, and strategies: a systemic review. Front Cell Dev Biol 10:991330","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"3365_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.2005.11.148","volume":"23","author":"H Brenner","year":"2005","unstructured":"Brenner H, Arndt V (2005) Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clin Oncol 23(3):441\u2013447","journal-title":"J Clin Oncol"},{"issue":"10","key":"3365_CR5","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1007\/s12094-024-03508-2","volume":"26","author":"V Dahiya","year":"2024","unstructured":"Dahiya V, Hans S, Kumari R, Bagchi G (2024) Prostate cancer biomarkers: from early diagnosis to precision treatment. Clin Transl Oncol 26(10):2444\u20132456","journal-title":"Clin Transl Oncol"},{"issue":"24","key":"3365_CR6","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan H-J (2017) The diagnosis and treatment of prostate cancer: a review. JAMA 317(24):2532\u20132542","journal-title":"JAMA"},{"issue":"9","key":"3365_CR7","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.3390\/ijms22094367","volume":"22","author":"S Salciccia","year":"2021","unstructured":"Salciccia S, Capriotti AL, Lagan\u00e0 A, Fais S, Logozzi M, De Berardinis E et al (2021) Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes. Int J Mol Sci 22(9):4367","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3365_CR8","doi-asserted-by":"publisher","first-page":"e0260983","DOI":"10.1371\/journal.pone.0260983","volume":"16","author":"L Luo","year":"2021","unstructured":"Luo L, Zhang L-L, Tao W, Xia T-L, Li L-Y (2021) Prediction of potential prognostic biomarkers in metastatic prostate cancer based on a circular RNA-mediated competing endogenous RNA regulatory network. PLoS ONE 16(12):e0260983","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"3365_CR9","first-page":"85","volume":"127","author":"YC Lin","year":"2014","unstructured":"Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB (2014) Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. J Cell Sci 127(Pt 1):85\u2013100","journal-title":"J Cell Sci"},{"issue":"4","key":"3365_CR10","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3892\/or.2015.3790","volume":"33","author":"Q Song","year":"2015","unstructured":"Song Q, Li C, Feng X, Yu A, Tang H, Peng Z, Wang X (2015) Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer. Oncol Rep 33(4):1956\u20131964","journal-title":"Oncol Rep"},{"issue":"1","key":"3365_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/19336950.2021.1965422","volume":"15","author":"J Li","year":"2021","unstructured":"Li J, Xie J, Wu D, Chen L, Gong Z, Wu R et al (2021) A pan-cancer analysis revealed the role of the SLC16 family in cancer. Channels (Austin) 15(1):528\u2013540","journal-title":"Channels (Austin)"},{"issue":"3","key":"3365_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3727\/096504016X14747335734344","volume":"25","author":"E Guo","year":"2017","unstructured":"Guo E, Liu H, Liu X (2017) Overexpression of SCUBE2 inhibits proliferation, migration, and invasion in glioma cells. Oncol Res 25(3):437\u2013444","journal-title":"Oncol Res"},{"issue":"1","key":"3365_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-023-00925-3","volume":"30","author":"Y-C Lin","year":"2023","unstructured":"Lin Y-C, Sahoo BK, Gau S-S, Yang R-B (2023) The biology of SCUBE. J Biomed Sci 30(1):33","journal-title":"J Biomed Sci"},{"issue":"11","key":"3365_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/iub.2560","volume":"73","author":"X Meng","year":"2021","unstructured":"Meng X, Yuan H, Li W, Xiong Z, Dong W, Xiao W, Zhang X (2021) Solute carrier family 16 member 5 downregulation and its methylation might serve as a prognostic indicator of prostate cancer. IUBMB Life 73(11):1363\u20131377","journal-title":"IUBMB Life"},{"issue":"1","key":"3365_CR15","doi-asserted-by":"publisher","first-page":"12954","DOI":"10.1038\/s41598-020-69814-1","volume":"10","author":"SM Waldstein","year":"2020","unstructured":"Waldstein SM, Seeb\u00f6ck P, Donner R, Sadeghipour A, Bogunovi\u0107 H, Osborne A, Schmidt-Erfurth U (2020) Unbiased identification of novel subclinical imaging biomarkers using unsupervised deep learning. Sci Rep 10(1):12954","journal-title":"Sci Rep"},{"key":"3365_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI (2015) Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J 13:8\u201317","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"3365_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12874-019-0681-4","volume":"19","author":"JAM Sidey-Gibbons","year":"2019","unstructured":"Sidey-Gibbons JAM, Sidey-Gibbons CJ (2019) Machine learning in medicine: a practical introduction. BMC Med Res Methodol 19(1):64","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3365_CR18","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1038\/s41598-022-07217-0","volume":"12","author":"N Singhal","year":"2022","unstructured":"Singhal N, Soni S, Bonthu S, Chattopadhyay N, Samanta P, Joshi U et al (2022) A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies. Sci Rep 12(1):3383","journal-title":"Sci Rep"},{"key":"3365_CR19","doi-asserted-by":"crossref","unstructured":"Park MK, Lim JM, Jeong J, Jang Y, Lee JW, Lee JC et al (2022) Deep-learning algorithm and concomitant biomarker identification for NSCLC prediction using multi-omics data integration. Biomolecules 12(12):1839","DOI":"10.3390\/biom12121839"},{"issue":"4","key":"3365_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/sam.11583","volume":"15","author":"VR Joseph","year":"2022","unstructured":"Joseph VR (2022) Optimal ratio for data splitting. Statistical Analysis and Data Mining: The ASA Data Science Journal 15(4):531\u2013538","journal-title":"Statistical Analysis and Data Mining: The ASA Data Science Journal"},{"key":"3365_CR21","doi-asserted-by":"publisher","first-page":"7365913","DOI":"10.1155\/2019\/7365913","volume":"2019","author":"Y Dong","year":"2019","unstructured":"Dong Y, Kang H, Liu H, Wang J, Guo Q, Song C et al (2019) Myoferlin, a membrane protein with emerging oncogenic roles. Biomed Res Int 2019:7365913","journal-title":"Biomed Res Int"},{"issue":"17","key":"3365_CR22","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1158\/0008-5472.CAN-13-1142","volume":"73","author":"A Turtoi","year":"2013","unstructured":"Turtoi A, Blomme A, Bellahc\u00e8ne A, Gilles C, Hennequi\u00e8re V, Peixoto P et al (2013) Myoferlin is a key regulator of EGFR activity in breast cancer. Can Res 73(17):5438\u20135448","journal-title":"Can Res"},{"issue":"27","key":"3365_CR23","doi-asserted-by":"publisher","first-page":"19209","DOI":"10.18632\/oncotarget.24971","volume":"9","author":"VR Barnhouse","year":"2018","unstructured":"Barnhouse VR, Weist JL, Shukla VC, Ghadiali SN, Kniss DA, Leight JL (2018) Myoferlin regulates epithelial cancer cell plasticity and migration through autocrine TGF-\u03b21 signaling. Oncotarget 9(27):19209\u201319222","journal-title":"Oncotarget"},{"key":"3365_CR24","doi-asserted-by":"publisher","first-page":"2602322","DOI":"10.1155\/2021\/2602322","volume":"2021","author":"R Pi","year":"2021","unstructured":"Pi R, Chen Y, Du Y, Dong S (2021) Comprehensive analysis of myoferlin in human pancreatic cancer via bioinformatics. Biomed Res Int 2021:2602322","journal-title":"Biomed Res Int"},{"issue":"1","key":"3365_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12672-024-00983-5","volume":"15","author":"X Xiao","year":"2024","unstructured":"Xiao X, Qing L, Li Z, Ye F, Dong Y, Mi J, Tian J (2024) Identification and validation of diagnostic and prognostic biomarkers in prostate cancer based on WGCNA. Discover Oncology 15(1):131","journal-title":"Discover Oncology"},{"key":"3365_CR26","doi-asserted-by":"crossref","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S et al (2016) The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54(1):1.30.1\u20131.30.33","DOI":"10.1002\/cpbi.5"},{"key":"3365_CR27","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.2147\/CMAR.S235500","volume":"12","author":"W Hu","year":"2020","unstructured":"Hu W, Li S, Zhang S, Xie B, Zheng M, Sun J et al (2020) GJA1 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer. Cancer Manag Res 12:11649\u201311661","journal-title":"Cancer Manag Res"},{"key":"3365_CR28","doi-asserted-by":"publisher","first-page":"8827920","DOI":"10.1155\/2020\/8827920","volume":"2020","author":"S Meng","year":"2020","unstructured":"Meng S, Fan X, Zhang J, An R, Li S (2020) GJA1 expression and its prognostic value in cervical cancer. Biomed Res Int 2020:8827920","journal-title":"Biomed Res Int"},{"key":"3365_CR29","doi-asserted-by":"crossref","unstructured":"Boucher J, Balandre AC, Debant M, Vix J, Harnois T, Bourmeyster N et al (2020) Cx43 present at the leading edge membrane governs promigratory effects of osteoblast-conditioned medium on human prostate cancer cells in the context of bone metastasis. Cancers (Basel) 12(10):3013","DOI":"10.3390\/cancers12103013"},{"key":"3365_CR30","doi-asserted-by":"publisher","first-page":"1117307","DOI":"10.3389\/fsurg.2022.1117307","volume":"9","author":"L Cheng","year":"2022","unstructured":"Cheng L, Zou X, Wang J, Zhang J, Mo Z, Huang H (2022) The role of CRYAB in tumor prognosis and immune infiltration: a Pan-cancer analysis. Front Surg 9:1117307","journal-title":"Front Surg"},{"issue":"7","key":"3365_CR31","first-page":"579","volume":"29","author":"CL Zhang","year":"2023","unstructured":"Zhang CL, Hu Y, Wang DX, Yang Q, Chang DH (2023) Research on the anti-tumor effects of CRYAB in prostate cancer. Zhonghua Nan Ke Xue 29(7):579\u2013286","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"3","key":"3365_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0002-9440(10)64244-7","volume":"161","author":"R Kuefer","year":"2002","unstructured":"Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H et al (2002) alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 161(3):841\u2013848","journal-title":"Am J Pathol"},{"key":"3365_CR33","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.2147\/OTT.S242406","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zheng A, Lu H, Jin Z, Peng Z, Jin F (2020) The expression and prognostic significance of Claudin-8 and androgen receptor in breast cancer. Onco Targets Ther 13:3437\u20133448","journal-title":"Onco Targets Ther"},{"key":"3365_CR34","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.2147\/CMAR.S189558","volume":"11","author":"B Cheng","year":"2019","unstructured":"Cheng B, Rong A, Zhou Q, Li W (2019) CLDN8 promotes colorectal cancer cell proliferation, migration, and invasion by activating MAPK\/ERK signaling. Cancer Manag Res 11:3741\u20133751","journal-title":"Cancer Manag Res"},{"issue":"7","key":"3365_CR35","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/cas.13269","volume":"108","author":"D Ashikari","year":"2017","unstructured":"Ashikari D, Takayama KI, Obinata D, Takahashi S, Inoue S (2017) CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration. Cancer Sci 108(7):1386\u20131393","journal-title":"Cancer Sci"},{"issue":"4","key":"3365_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/cts.12551","volume":"11","author":"P Fisel","year":"2018","unstructured":"Fisel P, Schaeffeler E, Schwab M (2018) Clinical and functional relevance of the monocarboxylate transporter family in disease pathophysiology and drug therapy. Clin Transl Sci 11(4):352\u2013364","journal-title":"Clin Transl Sci"},{"issue":"1","key":"3365_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12964-024-01897-z","volume":"22","author":"S Zheng","year":"2024","unstructured":"Zheng S, Hong Z, Tan Y, Wang Y, Li J, Zhang Z et al (2024) MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway. Cell Communication and Signaling 22(1):517","journal-title":"Cell Communication and Signaling"},{"issue":"3","key":"3365_CR38","doi-asserted-by":"publisher","first-page":"C494","DOI":"10.1152\/ajpcell.00458.2004","volume":"288","author":"TM Williams","year":"2005","unstructured":"Williams TM, Lisanti MP (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288(3):C494\u2013C506","journal-title":"Am J Physiol Cell Physiol"},{"key":"3365_CR39","doi-asserted-by":"publisher","first-page":"562774","DOI":"10.3389\/fonc.2020.562774","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen P, Zhang YL, Xue B, Xu GY (2020) Association of Caveolin-1 expression with prostate cancer: a systematic review and meta-analysis. Front Oncol 10:562774","journal-title":"Front Oncol"},{"issue":"4","key":"3365_CR40","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3748\/wjg.v21.i4.1140","volume":"21","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Han FH, Yang SB, Hua LX, Wu JH, Zhan WH (2015) Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. World J Gastroenterol 21(4):1140\u20131147","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3365_CR41","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3892\/or.2011.1605","volume":"27","author":"P Zhan","year":"2012","unstructured":"Zhan P, Shen XK, Qian Q, Wang Q, Zhu JP, Zhang Y et al (2012) Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Oncol Rep 27(4):1072\u20131078","journal-title":"Oncol Rep"},{"key":"3365_CR42","doi-asserted-by":"crossref","unstructured":"Wang Z, Chen G, Yuan D, Wu P, Guo J, Lu Y, Wang Z (2024) Caveolin-1 promotes glioma proliferation and metastasis by enhancing EMT via mediating PAI-1 activation and its correlation with immune infiltrates. Heliyon 10(2):e24464","DOI":"10.1016\/j.heliyon.2024.e24464"},{"issue":"8","key":"3365_CR43","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/labinvest.2011.66","volume":"91","author":"B Goulet","year":"2011","unstructured":"Goulet B, Kennette W, Ablack A, Postenka CO, Hague MN, Mymryk JS et al (2011) Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis. Lab Invest 91(8):1181\u20131187","journal-title":"Lab Invest"},{"issue":"21","key":"3365_CR44","doi-asserted-by":"publisher","first-page":"11669","DOI":"10.1073\/pnas.93.21.11669","volume":"93","author":"S Sheng","year":"1996","unstructured":"Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R (1996) Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A 93(21):11669\u201311674","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3365_CR45","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1074\/jbc.275.9.6051","volume":"275","author":"Z Zou","year":"2000","unstructured":"Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW et al (2000) p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275(9):6051\u20136054","journal-title":"J Biol Chem"},{"key":"3365_CR46","doi-asserted-by":"publisher","first-page":"111759","DOI":"10.1016\/j.intimp.2024.111759","volume":"131","author":"B-X Liu","year":"2024","unstructured":"Liu B-X, Xie Y, Zhang J, Zeng S, Li J, Tao Q et al (2024) SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-\u03b1\/NF-\u03baB pathway. Int Immunopharmacol 131:111759","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"3365_CR47","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/1759-7714.15013","volume":"14","author":"X He","year":"2023","unstructured":"He X, Ma Y, Huang Z, Wang G, Wang W, Zhang R et al (2023) SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma. Thorac Cancer 14(23):2275\u20132287","journal-title":"Thorac Cancer"},{"issue":"1","key":"3365_CR48","doi-asserted-by":"publisher","first-page":"25776","DOI":"10.1038\/srep25776","volume":"6","author":"Y Cui","year":"2016","unstructured":"Cui Y, Cao W, Li Q, Shen H, Liu C, Deng J et al (2016) Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis. Sci Rep 6(1):25776","journal-title":"Sci Rep"},{"key":"3365_CR49","first-page":"403","volume":"12","author":"ES Kotova","year":"2020","unstructured":"Kotova ES, Savochkina YA, Doludin YV, Vasilyev AO, Prilepskay EA, Potoldykova NV et al (2020) Identification of clinically significant prostate cancer by combined PCA3 and AMACR mRNA detection in urine samples. Res Rep Urol 12:403\u2013413","journal-title":"Res Rep Urol"}],"container-title":["Medical & Biological Engineering & Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-025-03365-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11517-025-03365-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-025-03365-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:02:12Z","timestamp":1757955732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11517-025-03365-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3365"],"URL":"https:\/\/doi.org\/10.1007\/s11517-025-03365-3","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"type":"print","value":"0140-0118"},{"type":"electronic","value":"1741-0444"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data was downloaded from the GEO database. The data will remain publicly available for anyone in the research community. This article does not contain any studies with animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures consist of informed consent followed by GEO committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All images were produced by authors and those are the output of data analysis software.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission and\/or credit for reproduced images"}}]}}